Sarah focuses on rare neurodevelopmental and neurodegenerative diseases including Huntington’s disease and CACNA1A disorders. She brings more than a decade of neuroscience research experience across France and Canada, leading programs from novel model development and characterization through IND-enabling therapeutic studies. Sarah’s work reflects a strong commitment to translating science into tangible outcomes for rare disease patients.
Sarah earned her B.S. in biology, physiology, and adaptive cognition from Aix-Marseille University in France followed by an M.S. in neuroscience and neuropharmacology from the University de Bordeaux. Sarah studied mechanisms involved in cognitive decline following cerebral micro-angiopathy for her graduate work at the Universite Laval in Canada before joining the Rare Disease Translational Center at JAX.